Cumberland Pharmaceuticals Inc. Cash Provided by (Used in) Operating Activities, Discontinued Operations
Cumberland Pharmaceuticals Inc. (CPIX) reported Cash Provided by (Used in) Operating Activities, Discontinued Operations of $4.05 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations · last filed 2026-08-07
- Cumberland Pharmaceuticals Inc. cash provided by (used in) operating activities, discontinued operations for the quarter ending 2022-12-31 was $0.00, a 100.00% decline year-over-year.
- Cumberland Pharmaceuticals Inc. cash provided by (used in) operating activities, discontinued operations for the quarter ending 2022-09-30 was $0.00, a 100.00% decline year-over-year.
- Cumberland Pharmaceuticals Inc. cash provided by (used in) operating activities, discontinued operations for the quarter ending 2022-06-30 was $0.00, a 100.00% decline year-over-year.
- Cumberland Pharmaceuticals Inc. cash provided by (used in) operating activities, discontinued operations for the quarter ending 2022-03-31 was $0.00, a 100.00% decline year-over-year.
- Cumberland Pharmaceuticals Inc. cash provided by (used in) operating activities, discontinued operations for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- Cumberland Pharmaceuticals Inc. cash provided by (used in) operating activities, discontinued operations for fiscal 2021 was $1.99M, a 43.31% decline from fiscal 2020.
- Cumberland Pharmaceuticals Inc. cash provided by (used in) operating activities, discontinued operations for fiscal 2020 was $3.52M, a 36.17% decline from fiscal 2019.
- Cumberland Pharmaceuticals Inc. cash provided by (used in) operating activities, discontinued operations for fiscal 2019 was $5.51M, a 22.38% increase from fiscal 2018.
| Period end | Cash Provided by (Used in) Operating Activities, Discontinued Operations 3 month | Cash Provided by (Used in) Operating Activities, Discontinued Operations 6 month | Cash Provided by (Used in) Operating Activities, Discontinued Operations 9 month | Cash Provided by (Used in) Operating Activities, Discontinued Operations 12 month |
|---|---|---|---|---|
| 2026-06-30 | $4.05M 10-Q · filed 2026-08-07 | |||
| 2025-06-30 | $5.44M 10-Q · filed 2026-08-07 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-13 | $0.00 derived: sum of 2 quarters · filed 2023-03-13 | $0.00 derived: sum of 3 quarters · filed 2023-03-13 | $0.00 10-K · filed 2023-03-13 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $0.00 derived: sum of 2 quarters · filed 2022-11-14 | $0.00 10-Q · filed 2022-11-14 | $503.32K derived: sum of 4 quarters · filed 2023-03-13 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $0.00 10-Q · filed 2022-08-12 | $503.32K derived: sum of 3 quarters · filed 2023-03-13 | $1.00M derived: sum of 4 quarters · filed 2023-03-13 |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-13 | $503.32K derived: sum of 2 quarters · filed 2023-03-13 | $1.00M derived: sum of 3 quarters · filed 2023-03-13 | $1.50M derived: sum of 4 quarters · filed 2023-03-13 |
| 2021-12-31 | $503.32K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-13 | $1.00M derived: sum of 2 quarters · filed 2023-03-13 | $1.50M derived: sum of 3 quarters · filed 2023-03-13 | $1.99M 10-K · filed 2023-03-13 |
| 2021-09-30 | $496.79K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $995.59K derived: sum of 2 quarters · filed 2022-11-14 | $1.49M 10-Q · filed 2022-11-14 | $2.84M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $498.81K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $994.22K 10-Q · filed 2022-08-12 | $2.35M derived: sum of 3 quarters · filed 2022-08-12 | $3.14M derived: sum of 4 quarters · filed 2022-08-12 |
| 2021-03-31 | $495.41K 10-Q · filed 2022-05-13 | $1.85M derived: sum of 2 quarters · filed 2022-05-13 | $2.64M derived: sum of 3 quarters · filed 2022-05-13 | $2.68M derived: sum of 4 quarters · filed 2022-05-13 |
| 2020-12-31 | $1.35M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | $2.15M derived: sum of 2 quarters · filed 2022-03-11 | $2.19M derived: sum of 3 quarters · filed 2022-03-11 | $3.52M 10-K · filed 2022-03-11 |
| 2020-09-30 | $794.65K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $833.22K derived: sum of 2 quarters · filed 2021-11-12 | $2.17M 10-Q · filed 2021-11-12 | $5.19M derived: sum of 4 quarters · filed 2022-03-11 |
| 2020-06-30 | $38.57K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | $1.37M 10-Q · filed 2021-08-13 | $4.40M derived: sum of 3 quarters · filed 2022-03-11 | $5.32M derived: sum of 4 quarters · filed 2022-03-11 |
| 2020-03-31 | $1.33M 10-Q · filed 2021-05-14 | $4.36M derived: sum of 2 quarters · filed 2022-03-11 | $5.28M derived: sum of 3 quarters · filed 2022-03-11 | $6.61M derived: sum of 4 quarters · filed 2022-03-11 |
| 2019-12-31 | $3.03M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | $3.95M derived: sum of 2 quarters · filed 2022-03-11 | $5.28M derived: sum of 3 quarters · filed 2022-03-11 | $5.51M 10-K · filed 2022-03-11 |
| 2019-09-30 | $918.19K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13 | $2.25M derived: sum of 2 quarters · filed 2020-11-13 | $2.48M 10-Q · filed 2020-11-13 | |
| 2019-06-30 | $1.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | $1.57M 10-Q · filed 2020-08-14 | ||
| 2019-03-31 | $232.94K 10-Q · filed 2020-05-22 | |||
| 2018-12-31 | $4.50M 10-K · filed 2021-03-12 | |||
| 2017-12-31 | $3.96M 8-K · filed 2020-12-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |